Metraipolis › archive › dc_e286fa8e4da1

Identification of G4-regulated immune-related drug targets for prostate cancer based on G4 screen and machine learning — Europe PMC PMID:42358976

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42358976
DOI
10.3389/fimmu.2026.1806289
License (as archived)
solo-consultazione
Archived
2026-10-31T14:55:04.748Z
SHA-256 of the archived text
495a21114d0f707267efef2169b1cd05f829f3f4c8c093d959f9159164ce5d6a
Stable URL of this page
https://metraipolis.com/documento/dc_e286fa8e4da1

How to cite

Identification of G4-regulated immune-related drug targets for prostate cancer based on G4 screen and machine learning — Europe PMC PMID:42358976 — Europe PMC (en), https://europepmc.org/article/MED/42358976 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e286fa8e4da1 (Metraipolis archive dc_e286fa8e4da1, sha256 495a21114d0f707267efef2169b1cd05f829f3f4c8c093d959f9159164ce5d6a)
BibTeX
@misc{dce286fa8e4da1,
  title = {Identification of G4-regulated immune-related drug targets for prostate cancer based on G4 screen and machine learning — Europe PMC PMID:42358976},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42358976},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e286fa8e4da1; sha256 495a21114d0f707267efef2169b1cd05f829f3f4c8c093d959f9159164ce5d6a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42358976. Agents can read the archived copy with the MCP tool read_document.